<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref85">
 <label>85</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Modjarrad</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>George</surname>
    <given-names>SL</given-names>
   </name>
   <name>
    <surname>Stephenson</surname>
    <given-names>KE</given-names>
   </name>
   <name>
    <surname>Eckels</surname>
    <given-names>KH</given-names>
   </name>
   <name>
    <surname>De</surname>
    <given-names>La</given-names>
   </name>
   <name>
    <surname>Barrera</surname>
    <given-names>RA</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: Phase 1, randomised, double-blind, placebo-controlled clinical trials</article-title>
  <source>Lancet</source>
  <year>2018</year>
  <volume>391</volume>
  <fpage>563</fpage>
  <lpage>71</lpage>
  <pub-id pub-id-type="pmid">29217375</pub-id>
 </element-citation>
</ref>
